Stockscreener 앱 받기
5.08
7.17%
0.34
시간 외 거래:
5.08
Orchestra Biomed Holdings Inc 주식(OBIO)의 최신 뉴스
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference - GlobeNewswire
Insiders Buying Orchestra BioMed Holdings Might Wish They Invested More, Stock Gains 29% - Moomoo
Orchestra (OBIO) Q2 2026 Results: Profit Per Share Clears Its Benchmark for the Current Session; Investor Response: Shares Finish 19.92% Higher in Latest TradingInvestor Earnings Call - vinanet.vn
Orchestra (OBIO) Reported Results Review: EPS Prints Above Forecast for the Current Session; Price Action: Shares Close 19.92% Higher at the CloseProfit Recovery Report - vinanet.vn
Orchestra BioMed Loss Widens as Pivotal Trials Advance - MyChesCo
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Orchestra BioMed (OBIO) director withholds 3,761 shares to cover RSU tax bill - Stock Titan
Orchestra BioMed (OBIO) director uses 5,145 shares to cover RSU tax withholding - Stock Titan
Orchestra BioMed (OBIO) director has 4,885 shares withheld for RSU tax - Stock Titan
Orchestra BioMed (OBIO) director reports 4,238 RSU tax-withholding shares - Stock Titan
Orchestra BioMed (OBIO) Holds Gains at $4.45, Consolidating Between Key Technical LevelsComposite Profile - vinanet.vn
Research Analysts Offer Predictions for OBIO Q3 Earnings - MarketBeat
Wall Street Analysts Are Bullish on Top Healthcare Picks - theglobeandmail.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - simplywall.st
Piper Sandler Maintains Orchestra BioMed(OBIO.US) With Buy Rating, Raises Target Price to $10 - Moomoo
Orchestra BioMed Holdings, Inc. Stock 12‑Month Price Target Raised to $12.33, Implies 177% Upside - TradingView
Orchestra Biomed Holdings earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates - Investing News Network
OBIO Looks 87.4% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus
Orchestra BioMed reports $24.1M Q2 loss, secures $35M capital - scanx.trade
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Orchestra BioMed (NASDAQ:OBIO) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Orchestra BioMed Reports Q2 2026 Results and Updates Progress on BACKBEAT and Virtue Pivotal Trials - Moomoo
Orchestra BioMed (NASDAQ: OBIO) widens H1 2026 loss amid heavy R&D spend - Stock Titan
Orchestra BioMed (OBIO) Climbs 1.56% to $4.31 as Shares Hold Above Key SupportLast Point Support - vinanet.vn
Orchestra Biomed Holdings Inc (OBIO) Stock News Today - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Orchestra BioMed (OBIO) Insider Darren Sherman Sells 15,000 Shar - GuruFocus
Darren Sherman Sells 15,000 Shares of Orchestra BioMed (NASDAQ:OBIO) Stock - marketbeat.com
Orchestra BioMed (OBIO) insider sale under 10b5-1 plan on August 3, 2026 - Stock Titan
Orchestra BioMed (OBIO) Projected to Announce Quarterly Earnings on Tuesday - marketbeat.com
Orchestra BioMed (NASDAQ: OBIO) insider details Rule 144 sales of 45,000 shares - Stock Titan
Orchestra BioMed (OBIO) Holds Near $4.00 as Shares Test Support ZoneAnalyst Upgrade Stocks - vinanet.vn
Orchestra Biomed Holdings Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
OBIO|Orchestra Biomed Holdings Inc|Price:3.825|Chg%:+0.085 - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Income Statement - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Balance Sheet - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Institutional Confidence - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Orchestra BioMed Holdings, Inc. Revenue Breakdown – NASDAQ:OBIO - TradingView
Orchestra Biomed Holdings Inc (OBIO) Valuation: PE, PB & Fair Value Analysis - TradingKey
OBIO|Orchestra Biomed Holdings Inc|Price:3.980|Chg%:-0.010 - TradingKey
OBIO Q1 2026 Earnings: Narrower-Than-Expected Loss as Pre-Revenue Biotech Advances PipelineHealthcare Earnings Report - po-news-eg.net
Orchestra Biomed Holdings Inc - TradingKey
Orchestra BioMed (OBIO) Bounces 2.75% as Traders Eye Key Resistance at $3.93Rounding Bottom - dars.gov.et
Orchestra Biomed Holdings Inc (OBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Orchestra BioMed Hldgs Market Sentiment - Benzinga
TradingKey - TradingKey
OBIO|Orchestra Biomed Holdings Inc|Price:3.740|Chg%:+0.100 - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OBIO Q1 2026 Earnings: Narrower‑than‑Expected Loss as Company Advances PipelineEarnings Growth Analysis - Vinanet
Orchestra BioMed: Nearing The First Of Two Pivotal Readouts (NASDAQ:OBIO) - Seeking Alpha
Short Interest in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Grows By 79.5% - MarketBeat
OBIO Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts SentimentEPS Surprise History - vinanet.vn
Price to earnings forward of Orchestra BioMed Holdings, Inc. – BOATS:OBIO - TradingView
OBIOOrchestra BioMed Holdings Inc Latest SEC Filings - Finviz
Orchestra BioMed Holdings Inc. (NASDAQ: OBIO) Share Price, OBIO Stock News, OBIO Share Price & Updates - Kalkine
Insider Sell: Darren Sherman Sells 15,000 Shares of Orchestra Bi - GuruFocus
Orchestra BioMed (OBIO) insider sells 15,000 shares under 10b5-1 plan - Stock Titan
Form 144 Orchestra BioMed Holdings For: 1 July By Investing.com - Investing.com South Africa
0.86%
0.31%
자본화:
|
볼륨(24시간):